CM
TMO icon

Crestline Management’s Thermo Fisher Scientific TMO Stock Holding History

Crestline Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,487
Closed -$4.94M – 587
2024
Q4 		$4.94M Buy
+9,487
New +$5.22M 0.16% 141

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Crestline Management's TMO Position: Q1 2025 in Review

Crestline Management sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 9,487 shares — an estimated $4.94M sold.

Crestline Management first reported a position in TMO in Q4 2024 and held it in 1 quarter. The position peaked at $4.94M in Q4 2024. 2,571 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

  • Crestline Management reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
  • Crestline Management sold 9,487 Thermo Fisher Scientific shares in Q1 2025, an estimated $4.94M.
  • Crestline Management first reported a position in Thermo Fisher Scientific in Q4 2024 and held it in 1 quarter.
  • Crestline Management's Thermo Fisher Scientific position peaked at $4.94M in Q4 2024.
  • 2,571 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.